Free Trial

Rocket Pharmaceuticals (RCKTW) Competitors

Rocket Pharmaceuticals logo
$0.07 +0.02 (+30.05%)
Closing price 09:28 AM Eastern
Extended Trading
$0.07 0.00 (0.00%)
As of 09:28 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

RCKTW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, BCTXW, and CELUW

Should you be buying Rocket Pharmaceuticals stock or one of its competitors? The main competitors of Rocket Pharmaceuticals include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), and Celularity (CELUW). These companies are all part of the "pharmaceutical products" industry.

Rocket Pharmaceuticals vs.

180 Life Sciences (NASDAQ:ATNFW) and Rocket Pharmaceuticals (NASDAQ:RCKTW) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, media sentiment, dividends, earnings, risk, community ranking, analyst recommendations, profitability and valuation.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
180 Life SciencesN/AN/AN/AN/AN/A
Rocket PharmaceuticalsN/AN/AN/AN/AN/A

In the previous week, 180 Life Sciences and 180 Life Sciences both had 2 articles in the media. Rocket Pharmaceuticals' average media sentiment score of 1.38 beat 180 Life Sciences' score of 1.24 indicating that Rocket Pharmaceuticals is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
180 Life Sciences
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Rocket Pharmaceuticals
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

180 Life Sciences and Rocket Pharmaceuticals both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
180 Life SciencesN/AN/A
Rocket PharmaceuticalsN/AN/A

Company Net Margins Return on Equity Return on Assets
180 Life SciencesN/A N/A N/A
Rocket Pharmaceuticals N/A N/A N/A

Summary

Rocket Pharmaceuticals beats 180 Life Sciences on 1 of the 1 factors compared between the two stocks.

Get Rocket Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for RCKTW and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RCKTW vs. The Competition

MetricRocket PharmaceuticalsBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$124.50M$5.53B$7.93B
Dividend YieldN/A3.69%5.11%4.23%
P/E RatioN/A3.2022.5118.54
Price / SalesN/A4,249.11397.62103.30
Price / CashN/A13.0238.1834.62
Price / BookN/A33.706.734.25
Net IncomeN/A-$90.45M$3.22B$248.18M
7 Day PerformanceN/A4.30%1.58%1.25%
1 Month PerformanceN/A5.70%4.05%3.76%
1 Year PerformanceN/A93.95%15.75%5.28%

Rocket Pharmaceuticals Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RCKTW
Rocket Pharmaceuticals
N/A$0.07
+30.1%
N/A-39.2%$0.00N/A0.00240Positive News
Gap Down
ATNFW
180 Life Sciences
N/A$0.01
-2.5%
N/A-11.8%$0.00N/A0.007News Coverage
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522,000.000.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.02
+22.1%
N/AN/A$0.00N/A0.002Gap Down
AIMDW
Ainos
N/A$0.09
+9.6%
N/AN/A$0.00$20,729.000.0040Gap Down
ALVOW
Alvotech
N/A$1.11
-14.6%
N/A-59.3%$0.00$489.68M0.004Short Interest ↑
News Coverage
Negative News
Gap Down
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.03
flat
N/A-76.3%$0.00N/A0.0015
BFRIW
Biofrontera
N/A$0.05
-29.5%
N/AN/A$0.00$37.32M0.0070Gap Down
BTMDW
biote
N/A$0.01
-2.3%
N/A-89.9%$0.00$197.19M0.00N/AGap Down
BCTXW
BriaCell Therapeutics
N/A$0.13
+43.5%
N/A-86.8%$0.00N/A0.008Gap Down
High Trading Volume
CELUW
Celularity
N/A$0.04
+9.4%
N/A+14.0%$0.00$48.20M0.00220

Related Companies and Tools


This page (NASDAQ:RCKTW) was last updated on 5/1/2025 by MarketBeat.com Staff
From Our Partners